The call should be exiting with the new developments. Your post and time should be at the top also.
Fully contained and needing little fresh water , generator for power and most likely doable. I would guess a grower would run test for ammonia and add proper minerals. Easy connections should be no problem.
the whole industry is tearing up the losses. Most people are doubling down right here. They knew it would happen. ITS TIME!!!!!!!!!!!!!!!!!!!!!!!!!
Cramer wants an Index to show the real and unreal companies. This will be a part of the index some day. HOLD and be strong as the pull backs will be met by more buying. The run up from .5 to 1.5 is the standard 1/3 retracement or pull back. Athos believes that true Tai-Chi must adhere to the words written by the great masters of old. ... Pushing and pulling, back and forth, the chi adheres to the back and ... When you break a lotus loot in half, the fine strands of fiber do not break.
The TV don't lie. BASHERS DO IT ALL THOSE SEXY, eye candy , smart babes on CNN told me that POT was going to change life as we know it. With a twinkle in her I scheduled a Colorado trip.
He said it is no more dangerous then alcohol. The FED will not get in way of the states. The banks can use FED money from the federal reserve to loan to legal companies. 20 states legalized medical MJ. Its going well for Bill. I think the fix is in.
you don't understand the network of RXNB their subsidiary with PHOT . They own part of PHOT and CANX (OCI) partnership. I don't think you understand at all.
give it up clown. They are doing every thing they can at this point with the Canada health system. Every thing is in order to date with the 900 page application and right to build reply. The process is working and its the way Canada does it. You can not blame BILLL for the way the licensing system works. The major and town opened their arms to the facility as in the videos. It is more risky at this point not to have enough. We all wish we had more. Cover or be destroyed.
Hemp is at the forefront of the new MJ legalization movement. They are activists and well connected. They are introducing REVI to the industry in a big way. Liston to the calls and "partnering" is how they will grow. Get the industry leaders first. -YES
maybe they need to read more..... The industry is growing faster then the cell phone industry. This is a no brainer as these stocks have been shorted very heavy. They must have really shorted yesterday very heavy. TODAY THEY PAY full price as the longs post about their subsidiaries, China acreages, pharma products, spin offs, IPO possible, and real value in consulting and services.
JMP Securities, Noble Financial Capital Markets, Piper Jaffray, and Roth Capital Partners. Given the strong research coverage and the fact that Oppenheimer believes that NeuVax alone is worth $6 per share, investors should be extremely excited about the potential for upside surprise over the coming months. institutions own approximately 17 percent of the outstanding shares for Galena Biopharma. This represents a total value of nearly $70 million based on Galena’s latest market capitalization. That certainly indicates a high confidence level that the company is likely to succeed. During the last quarter, four new institutions took a stake in the company:
• Highland Capital Management: 800,000 shares
• Bridgeway Capital Management: 539,150 shares
• Dafna Capital Management: 375,000 shares
• UBS O’Connor: 349,400 shares
Galena Biopharma acquired Abstral from Orexo AB on March 18, 2013. Abstral was FDA approved in 2011 and is a fentanyl sublingual tablet for the management of breakthrough cancer pain in opioid tolerant patients. Patients suffering from cancer usually experience “background pain,” which can normally be controlled by pain medications. However, even these medications cannot stop “breakthrough pain,” which is moderate to severe “spikes” of pain. A few facts about breakthrough pain include:
• It usually affects 23 percent to 93 percent of all cancer patients with controlled every day pain
• The pain can come on suddenly and quickly, often without warning.
• It is often extremely painful and is usually described as “moderate” or “severe”.
• Normally lasts between 30 and 60 minutes.
• Episodes of breakthrough pain can occur 3-4 times a day.
Breakthrough pain is known to interfere with daily living, which is why Abstral has the potential for massive success.
Based upon the company’s shares outstanding of 106 m . Abstral could add roughly $6.65 per share (175 million x 4)/(105.24). Add that to the $6 value from NeuVax and Galena shareholders are looki